WHO ICTRP trial
Clinical Study of the Safety and Efficacy of BCMA-CART Cell in the Treatment of…
ChiCTR1800014955 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800014955 |
|---|---|
| Public title | Clinical Study of the Safety and Efficacy of BCMA-CART Cell in the Treatment of Relapsed or Refractory Multiple Myeloma (MM) |
| Scientific title | Clinical Study of the Safety and Efficacy of BCMA-CART Cell in the Treatment of Relapsed or Refractory Multiple Myeloma (MM) |
| Primary sponsor | Henan Province Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Relapsed or Refractory Multiple Myeloma (MM) |
| Interventions | Case series:BCMA CART |
| Registration date | Feb 25, 2018 |
| Target size | Case series:5 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: